| Dr Emily A Tobey, PHD | |
|
1966 Inwood Rd., Dallas, TX 75235-7298 | |
| (214) 905-3010 | |
| (214) 905-3022 |
| Full Name | Dr Emily A Tobey |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1966 Inwood Rd., Dallas, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003144650 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 17054 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Emily A Tobey, PHD 1966 Inwood Rd., Dallas, TX 75235-7298 Ph: (214) 905-3010 | Dr Emily A Tobey, PHD 1966 Inwood Rd., Dallas, TX 75235-7298 Ph: (214) 905-3010 |
News Archive
DNA barcoding developed by University of Guelph researchers has proven up to 88 per cent effective in authenticating natural health products, according to a new U of G study.
CEL-SCI Corporation announced today it has received approval from seven hospital Institutional Review Boards in India to begin enrollment of subjects for a Phase III clinical trial of Multikine, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer.
When most groups of mammalian cells are faced with a shortage of nutrients or oxygen, the phrase "every man for himself" is more apt than "all for one, one for all." Unlike colonies of bacteria, which often cooperate to thrive as a group, mammalian cells have never been observed to help one another out. But a new study led by a researcher at the Stanford University School of Medicine has shown that certain human embryonic stem cells, in times of stress, produce molecules that not only benefit themselves, but also help nearby cells survive.
Progestins are used in hormone replacement therapies to counteract the negative effects of estrogen on the uterus and reduce the risk of uterine cancer. However, evidence in recent studies and clinical trials has demonstrated that progestins increase the risk of breast cancer. Now, University of Missouri researchers have compared four types of progestins used in hormone replacement therapies and found significantly different outcomes on the progression of breast cancer in an animal model depending on the type of progestins used.
In a peer-reviewed commentary published in npj Digital Medicine, experts from Regenstrief Institute, Mayo Clinic and The Pew Charitable Trusts write that matching patient records from disparate sources is not only achievable, but fundamental to stem the tide of the current pandemic and allow for fast action for future highly contagious viruses.
› Verified 1 days ago
Mrs. Stephanie Ann Ryer, MS/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2428 Bahama Dr, Dallas, TX 75211 Phone: 214-948-3811 | |
Melissa L. Bostwick, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9441 Lbj Fwy Ste 104, Dallas, TX 75243 Phone: 866-575-9820 | |
Mrs. Mary Kay Giesecke, MS-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3205 Cornell Ave, Dallas, TX 75205 Phone: 214-505-5041 Fax: 214-522-9777 | |
Patricia Maria Torres, SLPA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12270 Coit Rd. #870, Dallas, TX 75251 Phone: 214-677-7649 | |
Tanya Santos, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14160 Dallas Pkwy Ste 415, Dallas, TX 75254 Phone: 972-385-0006 | |
Kasey Rehme, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7777 Forest Ln, Dallas, TX 75230 Phone: 972-566-7000 |